The Asian Scientist 100
Can Li
Institution
University of Hong Kong
Country
Hong Kong
Field
Engineering
Li is a recipient of the 2023 Croucher Tak Wah Mak Innovation Award for his research exploring the limitations of digital computers in performing tasks accomplished by the human brain, including recognising faces, reasoning based on vague information, and learning from experience.
(Photo: University of Hong Kong)
AWARDS
- 2023 Croucher Tak Wah Mak Innovation Award
Related articles
Accurately Measuring Plasma With Interference
Researchers have developed a method to precisely measure the electron density of plasma even at atmospheric pressure.
Fast Evolving Flu Viruses Spread More Among Adults
Scientists have shown how both human behavior and virus biology affect which strains of influenza are in circulation.
Test Scores And Dumplings
Yes, kids from dumpling-eating countries seem to do extraordinarily well on math and science tests, but at what cost?
Capillary Force Helps Nanostructures Self-Assemble
By combining laser printing and capillary action, researchers have developed a highly tunable method to synthesize nanostructures.
Sympathy For The Devil?
The casual sexism of Tim Hunt is not simply a joke but a consequence of decades of silence and inaction on sexism in science, writes Michael Eisen.
Asia’s Scientific Trailblazers: Professor Kazutoshi Mori
In this edition of Asia's Scientific Trailblazers, we feature Professor Kazutoshi Mori, who won the 2014 Lasker Prize for his work on the unfolded protein response.
Hydrophobic Surfaces Reduce Salt Solubility In Water
Hydrophobic or water-repelling surfaces can influence the solubility of salts in water, a finding which could inform the design of drugs and self-cleaning surfaces.
How Science Diplomacy Is Bridging The Two Koreas
Through joint initiatives such as the Pyongyang University of Science and Technology, science could help foster bilateral cooperation between North and South Korea.
Early Clinical Trial Success For Rheumatoid Arthritis Vaccine
A small clinical trial has shown that a dendritic cell-based vaccine against citrullinated peptides could treat rheumatoid arthritis.